Found 18 matching trials
Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
PHASE3BBR 2778 is a novel aza-anthracenedione that has activity in experimental t...
Location
Northwest Alabama Cancer Center
Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
PHASE3The purpose of this study is to determine whether combining pixantrone (BBR...
Location
Arizona Clinical Research Center
Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment
PHASE1This study will be conducted in patients with metastatic cancer and either ...
Location
UTHSCSA-Cancer Therapy-Research Center
IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
PHASE1This is a phase I trial of the combination of bendamustine, rituximab and p...
Location
Duke University Medical Center
Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)
PHASE1The goal of this study is to find the safest dose of Pixantrone (BBR 2778) ...
Location
MD Anderson Cancer Center
Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients
N/ARetrospective/prospective observational multicentric study aimed at describ...
Status
Active Not Recruiting
Location
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
PHASE1The aim of this trial is to determine the appropriate dose of pixantrone to...
Location
Arizona Clinical Research Center
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
PHASE1RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Location
Arizona Clinical Research Center
Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
PHASE1This is a phase 1, open-label, dose escalation study to evaluate the safety...
Location
Children's Hospital Los Angeles
Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
PHASE2This study will evaluate the efficacy of Pixantrone with rituximab, ifosfam...